Ongoing demand for large-scale APIs combined with high capacity utilization has driven Cambrex Corporation to allot up to $85m for manufacturing expansion in 2015. The Charles City, Iowa facility manufactures active pharmaceutical ingredients , fine chemicals and pharmaceutical intermediates, and will benefit from a second expansion of $45-50m to in as many years in order to support increased customer demand.